Huntress, known for stopping cyber threats at a record pace, is entering the high-stakes world of motorsport through a ...

Gradient Racing will premiere its new Ford Mustang GT3 at the upcoming Rolex 24 At Daytona, and the Austin-based team has ...

Huntress Founder & CEO Kyle Hanslovan is set to accelerate the cybersecurity game by teaming up with Forte Racing’s IMSA ...

Paul Miller Racing revealed their 2025 full-time driver lineups Tuesday morning (Jan. 14). The team previously announced ...

In 2023 the team expanded to include an IMSA WeatherTech GTD entry with their ... and included a 2nd-place finish at Indianapolis and VIR, along with a win at the 2023 season-finale Petit Le ...

22 _ Men’s Soccer, German Bundesliga season begins. 22-24 _ Auto racing, IMSA SportsCar, Michelin GT Challenge at VIR, Alton, Va. 22-24 _ Cycling, UCI BMX Racing, Lumberjack Nationals, Richland, Wash.

Vir Biotechnology's recent share price rally is driven by their promising cancer program, despite their primary focus on hepatitis management. The company's market cap has surged past $1 billion ...

Shares of Vir Biotechnology (NASDAQ:VIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data for two antitumor agents developed using its PRO-XTEN masking ...

Compelling early clinical response signals for VIR-5818 and VIR-5500 in heavily pretreated patients with various solid tumors VIR-5818: In patients receiving doses ≥400 µg/kg, tumor ...

50% of patients receiving VIR-5818 doses ≥400 µg/kg showed tumor shrinkage. Morgan Stanley upgrades Vir Biotechnology to Overweight with a $20 price target. Data show encouraging preliminary ...

BofA lowered the firm’s price target on Vir Biotechnology (VIR) to $14 from $15 and keeps a Neutral rating on the shares. While political and rate uncertainty continues to be an overhang ...